Alere acquires Arriva Medical for $65 million, plus stock

12/2/2011 | Clinica (subscription required)

Arriva Medical, which supplies blood glucose monitors and other diabetes testing devices to patients' homes, has been acquired by in vitro diagnostics firm Alere for $65 million in cash, plus 806,452 restricted company shares. The deal will allow Alere to expand its footprint in the point-of-care diabetes diagnostics arena.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC